IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJ-D-16-00347

Annulus rupture post transcatheter aortic valve implantation complicated by a giant pseudoaneurysm

Thomas Thimon*, MD; Javier Molina-Martin de Nicolas, MD; Mathieu Lapeyre, MD; Didier Tchetche, MD

An 82-year-old man with symptomatic aortic stenosis was referred to our institution for transcatheter aortic valve implantation (TAVI), based on his comorbidities (STS score 6.63%). Multislice computed tomography (MSCT) identified a type 1 L/R bicuspid aortic valve. As the annular area-derived mean diameter was 29.1 mm and the intercommissural distance 30.1 mm, a 29 mm Edwards SAPIEN 3 (S3) prosthesis (Edwards Lifesciences, Irvine, CA, USA) was implanted via the transfemoral approach (Panel A-Panel C, Moving image 1). Post valve deployment, an annular rupture was identified by angiography, in the posterior zone of the aortic valve (Panel D, Moving image 2). As a bail-out strategy, pericardial drainage was carried out, quickly combined with the implantation of a second 29 mm S3 before protamine infusion. Haemodynamic recovery was thus obtained, without any obvious residual leak, either on angiography or on transthoracic echocardiography (Panel E, Moving image 3). The in-hospital course was uneventful, except for a complete atrioventricular block requiring a permanent pacemaker on day four. A control MSCT was performed on day 10, which identified good prostheses position with a large pseudoaneurysm of the aortic root located on the right side and extending on 46 mm alongside the aorta (Panel F-Panel H). The optimal management of stable aortic pseudoaneurysm formation in patients considered too frail for surgery is limited to case reports, and should therefore be discussed in a multidisciplinary setting.

The present patient remained haemodynamically stable after initial management and was asymptomatic during the in-hospital course. Considering frailty and surgical risk, a conservative approach was adopted with follow-up by MSCT.

At one-month follow-up, the patient was in NYHA Class I, no events were reported and MSCT confirmed the stability of the pseudoaneurysm (Panel I).

We report here for the first time the constitution of a giant and stable aortic pseudoaneurysm, post TAVI-related annular rupture.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. First Edwards SAPIEN 3 prosthesis implantation.

Moving image 2. Angiography of the annular rupture.

Moving image 3. Final result.

Supplementary data

To read the full content of this article, please download the PDF.

First Edwards SAPIEN 3 prosthesis implantation.

Angiography of the annular rupture.

Final result.

Volume 12 Number 15
Feb 3, 2017
Volume 12 Number 15
View full issue


Key metrics

Suggested by Cory

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00647 Jan 19, 2018
Percutaneous closure of subannular rupture following transcatheter aortic valve implantation
Shah S et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY15M02_06 Jul 20, 2015
Transcatheter Lotus valve implantation in a regurgitant SAPIEN 3 valve
Van Mieghem NM et al
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved